UBS Group’s THERATECHNOLOGIES INC COM THER Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-63,651
| Closed | -$53.5K | – | 10416 |
|
|
2023
Q2 | $53.5K | Sell |
63,651
-4,968
| -7% | -$4.18K | ﹤0.01% | 6436 |
|
|
2023
Q1 | $55.6K | Buy |
68,619
+3,493
| +5% | +$2.83K | ﹤0.01% | 6376 |
|
|
2022
Q4 | $57.3K | Sell |
65,126
-1,433
| -2% | -$1.26K | ﹤0.01% | 6640 |
|
|
2022
Q3 | $158K | Buy |
66,559
+5,299
| +9% | +$12.6K | ﹤0.01% | 5307 |
|
|
2022
Q2 | $139K | Sell |
61,260
-7,200
| -11% | -$16.3K | ﹤0.01% | 5184 |
|
|
2022
Q1 | $168K | Sell |
68,460
-13,004
| -16% | -$31.9K | ﹤0.01% | 5498 |
|
|
2021
Q4 | $247K | Sell |
81,464
-3,637
| -4% | -$11K | ﹤0.01% | 5508 |
|
|
2021
Q3 | $320K | Sell |
85,101
-2,043
| -2% | -$7.68K | ﹤0.01% | 4999 |
|
|
2021
Q2 | $338K | Buy |
87,144
+12,043
| +16% | +$46.7K | ﹤0.01% | 5004 |
|
|
2021
Q1 | $290K | Sell |
75,101
-58,862
| -44% | -$227K | ﹤0.01% | 5228 |
|
|
2020
Q4 | $335K | Buy |
133,963
+81,048
| +153% | +$203K | ﹤0.01% | 4895 |
|
|
2020
Q3 | $117K | Sell |
52,915
-674
| -1% | -$1.49K | ﹤0.01% | 5095 |
|
|
2020
Q2 | $107K | Sell |
53,589
-10,962
| -17% | -$21.9K | ﹤0.01% | 5251 |
|
|
2020
Q1 | $103K | Buy |
64,551
+24,700
| +62% | +$39.4K | ﹤0.01% | 5272 |
|
|
2019
Q4 | $131K | Buy |
+39,851
| New | +$131K | ﹤0.01% | 5865 |
|
Other funds holding THER
UBS Group's THER Position: Q3 2023 in Review
UBS Group sold out of THERATECHNOLOGIES INC COM (THER) in Q3 2023, closing a stake of 63,651 shares — an estimated $53.5K sold.
UBS Group first reported a position in THER in Q4 2019 and held it in 15 quarters. The position peaked at $338K in Q2 2021. 2 funds tracked by Wall St. Rank hold THER as of Q3 2023.
- UBS Group reported no remaining THERATECHNOLOGIES INC COM position as of Q3 2023 after selling out during the quarter.
- UBS Group sold 63,651 THERATECHNOLOGIES INC COM shares in Q3 2023, an estimated $53.5K.
- UBS Group first reported a position in THERATECHNOLOGIES INC COM in Q4 2019 and held it in 15 quarters.
- UBS Group's THERATECHNOLOGIES INC COM position peaked at $338K in Q2 2021.
- 2 funds tracked by Wall St. Rank held THERATECHNOLOGIES INC COM as of Q3 2023.
Based on UBS Group's 13F filing for Q3 2023, filed 9 Nov 2023.